Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia

International Journal of Urology

Volumn 18, Issue 3, 2011, Pages 243-248

  Simaioforidis, Vasileios ^a   Papatsoris, Athanasios G ^b   Chrisofos, Michael ^b   Chrisafis, Manolis ^b   Koritsiadis, Sotirios ^a   Deliveliotis, Charalambos ^b  

^a Nikea General Hospital Athens   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

Author keywords

Nocturia; Prostate; Quality of life; Tamsulosin; Transurethral prostatectomy

Indexed keywords

TAMSULOSIN;

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; FOLLOW UP; FREQUENCY VOLUME CHART; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL CONSULTATION ON INCONTINENCE QUESTIONNAIRE NOCTURIA; INTERNATIONAL CONSULTATION ON INCONTINENCE QUESTIONNAIRE NOCTURIA QUALITY OF LIFE; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP TIME; TRANSURETHRAL RESECTION; URINARY FREQUENCY;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SULFONAMIDES; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 79951799438     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02704.x     Document Type: Article

References (21)

1. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br. J. Urol. 1994; 74: 551-5.
2. Van Dijk M, Wijkstra H, Debruyne FM, De la Rosette JJMC, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2010; 105: 1141-6.
3. Papatsoris AG, Gekas A. Which is the association between erectile dysfunction and lower urinary tract symptoms? Andrologia 2004; 36: 402-3.
4. Nishizawa O, Araki I, Ishizuka O etal. Clinical guidelines for nocturia. Int. J. Urol. 2010; 17: 397-409.
5. Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: etiology and classification. Neurourol. Urodyn. 1998; 17: 467-72.
6. Abraham L, Hareendran A, Mils I etal. Development and validation of a quality-of-life measure for men with nocturia. Urology 2004; 63: 481-6.
7. Cardozo L, Coyne KS, Versi E. Validation of the urgency perception scale. BJU Int. 2005; 95: 591-6.
8. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999; 84: 297-301.
9. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks. Eur. Urol. Suppl. 2005; 3: 24-32.
10. Choo MS, Ku JH, Park CH etal. Prevalence of nocturia in a Korean population aged 40 to 89years. Neurourol. Urodyn. 2008; 27: 60-4.
11. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology 2007; 70: 493-7.
12. Yoshida M, Inadome A, Masunaga K, Nagata T, Yoshiyasu T. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia. Neurourol. Urodyn. 2010; 29: 1276-81.
13. Djavan B, Milania S, Davies J, Bolodeoku J. The impact of tamsulosin Oral Controlled Absorption System (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study. Eur. Urol. Suppl. 2005; 4: 61-8.
14. Van Kerrebroeck P, Abrams P, Chaikin D etal. The standardization if terminology in nocturia: report from the Standardization Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002; 21: 179-83.
15. Kaplan SA. Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia. Rev. Urol. 2006; 8: 10-17.
16. Vallancien G, Emberton M, Alcaraz A etal. Alfuzosin 10mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real life practice. BJU Int. 2008; 101: 847-52.
17. Paick JS, Ku JH, Shin JW, Yang JH, Kim SW. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int. 2006; 97: 1017-23.
18. Nishino M, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int. 2006; 97: 747-51.
19. Gotoh M, Kamihira O, Kinukawa T, Ono Y, Ohsima S, Origasa H. Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial. BJU Int. 2005; 96: 581-6.
20. Iwaki H, Narita M, Soga H, Sakano Y, Konishi T, Okada Y. Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia. Hinyokika Kiyo 2010; 56: 209-13.
21. Johnson TM, Burrows PK, Kusek JW etal. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J. Urol. 2007; 178: 2045-50.